Therapy Areas: Vaccines
BioNTech states no role for its COVID-19 vaccine in UK challenge trial
24 September 2020 -

German biotechnology company BioNTech SE (Nasdaq:BNTX), the development partner with Pfizer for a COVID-19 vaccine, on 24 September 2020 joined other leading COVID-19 vaccine developers in ruling out participation in Britain's plans to test experimental inoculations by deliberately infecting trial volunteers.

According to a spokesman of the company, "BioNTech's vaccine candidate is not part of this study."

Britain said it was working with partners on the potential for human challenge trials without commenting on a specific plan.

AstraZeneca and Sanofi both have said their vaccine candidates were not involved in the programme, Reuters added.

Login
Username:

Password:


Related Headlines

UK Medicines and Healthcare products Regulatory Agency Begins Rolling Review of Moderna's mRNA Vaccine Against COVID-19

Support from the US Department of Defense Will Accelerate Progress on Vaccine Candidate for COVID-19, IAVI Says

University of Cambridge Receives Funding for Clinical Trial Using PharmaJet's Needle-free System to Deliver Vaccine to Prevent COVID-19

Kantaro Biosciences LLC and Bio-Techne Corporation announce receipt of CE mark for COVID-SeroKlir and COVID-SeroIndex quantitative SARS-CoV-2 IgG antibody test kits

New UK study shows evidence of waning antibody immunity to COVID-19 over time

Moderna Inks Supply Agreement with the Ministry of Public Health to Supply Qatar with mRNA Vaccine Against COVID-19 (mRNA-1273)

Precision NanoSystems Will Receive CDN 18.2m from the government of Canada to Develop an RNA Vaccine for COVID-19

Aerogen Collaborates on Development of More Than 15 Potential COVID-19 Inhaled Therapies

Aerogen to develop 15 potential COVID-19 inhaled therapies in partnership with pharmaceutical companies

Singapore's health ministry temporarily halts use of two influenza vaccines after deaths in South Korea

Early trial results of Oxford University and AstraZeneca's COVID-19 vaccine indicate it produces robust immune response in elderly

Trans-Hit Biomarkers Partners with Nexelis to Support Sample Procurement Activities for a Number of Strategic Projects Including COVID-19 Vaccines

IAVI, Merck, and Serum Institute of India Team to Develop Monoclonal Antibodies for COVID-19

Aerogen Collaborates on Development of More Than 15 Potential COVID-19 Inhaled Therapies

CureVac reports positive pre-clinical data for its potential COVID-19 vaccine